Insider Transactions in Q3 2025 at Optimize Rx Corp (OPRX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 28
2025
|
Patrick D Spangler Director |
SELL
Open market or private sale
|
Direct |
11,120
-20.1%
|
$189,040
$17.49 P/Share
|
|
Aug 21
2025
|
Brendan W. Merrell CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,417
+27.34%
|
-
|
|
Aug 21
2025
|
Andrew J. D'Silva Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,417
+17.98%
|
-
|
|
Aug 21
2025
|
Stephen L Silvestro Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+7.83%
|
-
|
|
Aug 21
2025
|
Marion Odence Ford Chief Legal & Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+15.39%
|
-
|
|
Aug 21
2025
|
Edward Stelmakh Chief Finance & Strat Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+12.36%
|
-
|
|
Aug 21
2025
|
Doug Besch Chief Product & Tech Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+18.86%
|
-
|
|
Aug 21
2025
|
Theresa Greco Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,625
+17.06%
|
-
|